| 000 | 01631nam a22003137a 4500 | ||
|---|---|---|---|
| 005 | 20261118125048.0 | ||
| 008 | 261118s2008 |||||||| |||| 00| 0 eng d | ||
| 020 | _a9781420044355 | ||
| 040 | _cPK-LaUMT | ||
| 082 |
_a615.6 _bMOD- |
||
| 245 | 0 | 0 |
_aModified-release drug delivery technology / _cedited by Michael J. Rathbone . . . [et al.] |
| 250 | _a2nd ed. | ||
| 260 |
_aNew York : _bInforma Healthcare, _c2008 |
||
| 300 | _a2 vols | ||
| 490 |
_aDrugs and the pharmaceutical sciences ; _vV.183 |
||
| 500 | _aIncludes bibliographical references and index. | ||
| 520 | _aThis two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes, found in areas like:Oral Ocular Dermal and transdermal VaginalColonic Oral mucosal Nasal PulmonaryProviding insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value, topics include:Intellectual property rights and regulatory issues and challengesosmotic systems and Qtrol. Qdis. Matrix Systemsthiolated polymers for CR, Oradur. IDD technology, and chronotherapy technologyOral-lynTM | ||
| 546 | _aEng | ||
| 650 |
_aControlled release preparations _917494 |
||
| 650 |
_aControlled release technology _917495 |
||
| 650 |
_aDrug Delivery Systems _98913 |
||
| 650 |
_aPharmaceutical technology _917496 |
||
| 650 |
_aTechnology, Pharmaceutical _917497 |
||
| 700 | 1 |
_aRathbone, Michael J. _917498 |
|
| 700 | 1 |
_aHadgraft, Jonathan _917499 |
|
| 700 | 1 |
_aRoberts, Michael S. _917500 |
|
| 700 | 1 |
_aLane, Majella E. _917501 |
|
| 942 | _cBK | ||
| 999 |
_c144069 _d144069 |
||